Cancer Today’s Summer 2025 Issue: Expanded Use of Neoadjuvant Immunotherapy, PSMA-targeted Therapy in Prostate Cancer, and More
Cancer Today's 2025 summer issue covers the expanded use of neoadjuvant immunotherapy, PSMA-targeted therapy for prostate cancer, and more.